Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock closed at $14.57 on 1/5/24 after a major decline of -14.8%. Moreover, exceptionally high trading volume at 570% of normal accompanied the decline. The stock has been strong relative […]
Stock Rating Downgrade The Value Trend Rating for Inotiv Inc (NASDAQ: NOTV) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Mitek Systems Inc (NASDAQ: MITK) improved in recent days. MITK’s current Value Trend Rating is B and the prior Rating […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Logan Ridge Finance Corp (NASDAQ: LRFC) weakened recently. LRFC’s current Value Trend Rating is C and the prior Rating was […]
Stock Rating Upgrade The Value Trend Rating for Farmers & Merchants Bancorp Inc (NASDAQ: FMAO) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Stock Rating Upgrade In the last week the Value Trend Rating for Micron Technology Inc. (NASDAQ: MU) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action Micron Technology Inc. […]
Stock Rating Upgrade In recent days the Value Trend Rating for Visteon Corp. (NASDAQ: VC) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 1/5/24, Visteon Corp. (NASDAQ: […]
Stock Rating Downgrade In the last week the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/5/24, Neurocrine […]
On 1/4/24, Crexendo Inc (NASDAQ: CXDO) stock suffered a major decline of -11.0%, closing at $4.24. Moreover, trading volume in this decline was unusually high at 192% of normal. Relative to the market the stock […]
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock enjoyed a major increase of 13.8% on 1/4/24. The shares closed at $12.04. Moreover, trading volume in this advance was exceptionally high at 267% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research